The outbreak of Coronavirus disease 2019 (COVID-19) has evolved into an emergent global
pandemic. Many drugs without established efficacy are being used to treat COVID-19 …

Bilirubin is an end product of heme degradation by heme oxygenases (HOs). At high
concentrations, bilirubin acts as a highly cytotoxic metabolite, which can cause brain …

In the absence of a cure, HIV-infected patients are being successfully treated with
antiretroviral therapies (ART) and living longer. Indeed, an increasing number of HIV …

Given advances in antiretroviral therapy, the mortality rate for HIV infection has dropped
considerably over recent decades. However, people living with HIV (PLWH) experience …

Objective As guidelines are evolving towards recommending starting antiretroviral therapy
(ART) in all HIV‐positive individuals irrespective of clinical and immunological status, HIV …

Background Cardiovascular disease is currently the leading cause of death in patients with
human immunodeficiency virus on combination antiretroviral therapy. Although the use of …

Thanks to the advent of combination antiretroviral therapy (cART), people living with human
immunodeficiency virus (HIV)(PLWH) experienced a marked increase in life expectancy but …

With advances in antiretroviral therapy (ART), individuals with human immunodeficiency
virus (HIV) infection are living longer and increasingly die of non–HIV-related diseases, such …

An estimated 34 million men, women, and children are infected with human
immunodeficiency virus type 1 (HIV-1), the virus that causes acquired immunodeficiency …

In the past 15 years, improvements in the management of HIV infection have dramatically
reduced morbidity and mortality. Similarly, rapid advances in antiretroviral medications have …